Bradley Foster & Sargent Inc Gsk PLC Transaction History

Bradley Foster & Sargent Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $19,931 - $22,642	-474 Reduced 6.22%	7,142 $311,000
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $306,391 - $363,587	7,616 New	7,616 $332,000
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $258,046 - $302,505	-7,574 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$38.11 - $42.99 $10,480 - $11,822	275 Added 3.77%	7,574 $285,000
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $34,093 - $51,271	-1,050 Reduced 12.58%	7,299 $277,000
Q4 2019 Jan 29, 2020	BUY	$42.0 - $48.25 $15,582 - $17,900	371 Added 4.65%	8,349 $392,000
Q2 2019 Aug 08, 2019	BUY	$39.4 - $42.7 $4,491 - $4,867	114 Added 1.45%	7,978 $319,000
Q1 2019 May 02, 2019	BUY	$38.57 - $42.69 $19,940 - $22,070	517 Added 7.04%	7,864 $329,000
Q4 2018 Jan 30, 2019	BUY	$37.8 - $42.69 $33,717 - $38,079	892 Added 13.82%	7,347 $281,000
Q3 2018 Oct 31, 2018	BUY	$39.75 - $42.69 $256,586 - $275,563	6,455 New	6,455 $259,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.